Beyond tissue concentrations: antifungal penetration at the site of infection
- PMID: 30816968
- PMCID: PMC6506603
- DOI: 10.1093/mmy/myy067
Beyond tissue concentrations: antifungal penetration at the site of infection
Abstract
Despite advances in antifungal therapy, invasive fungal infections remain a significant cause of morbidity and mortality worldwide. One important factor contributing to the relative ineffectiveness of existing antifungal drugs is insufficient drug exposure at the site of infection. Despite the importance of this aspect of antifungal therapy, we generally lack a full appreciation of how antifungal drugs distribute, penetrate, and interact with their target organisms in different tissue subcompartments. A better understanding of drug distribution will be critical to guide appropriate use of currently available antifungal drugs, as well as to aid development of new agents. Herein we briefly review current perspectives of antifungal drug exposure at the site of infection and describe a new technique, matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging, which has the potential to greatly expand our understanding of drug penetration.
Keywords: MALDI imaging; antifungals; drug quantification; posaconazole; site of infection; tissue penetration.
© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.
Figures
References
-
- Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012; 4: 165rv113. - PubMed
-
- Pappas PG, Kauffman CA, Andes DR et al. . Executive summary: Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016; 62: 409–417. - PubMed
-
- Heidelberger C, Chaudhuri NK, Danneberg P et al. . Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature. 1957; 179: 663–666. - PubMed
-
- Grunberg E, Titsworth E, Bennett M. Chemotherapeutic activity of 5-fluorocytosine. Antimicrob Agents Chemother (Bethesda). 1963; 161: 566–568. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
